The world pays attention to the successful case of the Ilyang Pharmaceutical’s leukemia treatment ‘Supect’

The successful case of the leukemia treatment, the domestically-developed new drug developed by Ilyang Pharmaceutical, ‘Supect,’ was introduced as the representative role model of the R&D and commercialization of a new innovative drug at the world’s largest bio international convention.

Ilyang Pharmaceutical (President Dong-yeon Kim), participated in the world’s largest biotechnology conferenc...